Measure NameMeasure CategoryPPRNet IDCMS QID / QCDR IDeCQMMIPS Reportable?
Cervical cancer screeningCancer Screening5.1309CMS124Yes
Breast cancer screening Cancer Screening5.2112CMS125Yes
Colorectal cancer screening Cancer Screening5.3113CMS130Yes
Controlling high blood pressure (BP) Cardiovascular Disease2.3236CMS165Yes
Concordance with ACC/AHA Cholesterol Guidelines for ASCVD Risk ReductionCardiovascular Disease2.5NANANo
Ischemic Vascular Disease: Use of aspirin or another antiplateletCardiovascular Disease2.6204CMS164Yes
Antiplatelet Medication for High Risk PatientsCardiovascular Disease2.7PPRNET8NAYes
Patients with atrial fibrillation with current anti-platelet or oral anticoagulant Rx Cardiovascular Disease2.8NANANo
Heart Failure (HF): ACE Inhibitor or ARB Therapy for Left Ventricular Systolic Dysfunction (LVSD)Cardiovascular Disease2.105CMS135Yes
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)Cardiovascular Disease2.118CMS144Yes
Patients screened for abdominal aortic aneurysmCardiovascular Disease2.12NANANo
Screening for albuminuria in patients at risk for CKD (DM and/or HTN)Chronic Kidney Disease 3.1PPRNET32NAYes
Monitoring for albuminuria in patients with CKDChronic Kidney Disease 3.2NANANo
Chronic Kidney Disease (CKD): Hemoglobin MonitoringChronic Kidney Disease 3.4PPRNET14NAYes
ACE Inhibitor or ARB Therapy in patients with HTN and Stage A2 or A3 AlbuminuriaChronic Kidney Disease 3.7NANANo
Screening for Type 2 Diabetes MellitusDiabetes Mellitus1.1PPRNET31NAYes
Diabetes: Hemoglobin A1c control (< 8%) Diabetes Mellitus1.4NANANo
Diabetes: Hemoglobin A1c (HbA1c) poor control (> 9%) Diabetes Mellitus1.51CMS122Yes
Nephropathy Assessment Diabetes Mellitus1.6119CMS134Yes
Diabetes: Foot examDiabetes Mellitus1.7163CMS123*No 
Diabetes: Eye examDiabetes Mellitus1.8117CMS131Yes
Influenza Immunizations7.2110CMS147Yes
Pneumococcal Vaccination Status for Older AdultsImmunizations7.3111CMS127Yes
Pneumococcal: high risk patients Immunizations7.4NANANo
Meningococcal Immunizations7.6NANANo
Zoster (shingles) Immunizations7.8PPRNET34NAYes
HIV screeningInfectious Disease Screening6.1NANANo
Hepatitis C ScreeningInfectious Disease Screening6.2400NAYes
Use of high-risk medications in the elderly  Medication Safety10.1238CMS156Yes
Use of Benzodiazepines in the ElderlyMedication Safety10.2NANANo
Appropriate dosages of H2 blockers in patients with decreased renal functionMedication Safety10.3NANANo
Monitoring Serum CreatinineMedication Safety10.8PPRNET29NAYes
Treatment of HypokalemiaMedication Safety10.10NANANo
Glucose measured in past year in patients with Rx for any antipsychoticMedication Safety10.12NANANo
Patients with Dx of A-fib and Warfarin Rx with INR within the therapeutic rangeMedication Safety10.14NANANo
Avoiding Use of CNS Depressants in Patients on Long-Term OpioidsMedication Safety10.15PPRNET33NAYes
Depression screening (adults)Mental Health and Substance Abuse8.1NANANo
Alcohol misuse: screening Mental Health and Substance Abuse8.3NANANo
Patients with alcohol diagnosis or at-risk drinking with alcohol counseling in past year Mental Health and Substance Abuse8.4NANANo
Tobacco Use: Screening and cessation intervention Mental Health and Substance Abuse8.6226CMS138Yes
PSA screening for prostate cancer in men age 70 years and olderOveruse 2NANANo
Vitamin D deficiency screening in patients age 18 years and olderOveruse 9NANANo
Appropriate Dosing of New Oral Anticoagulants (NOACs) in Patients with Renal Dysfunction Reducing ADEs1.3NANANo
Renal Function Monitoring for New Oral Anticoagulants (NOACs)Reducing ADEs1.4NANANo
Avoiding Potential Overtreatment of High Risk Patients with DiabetesReducing ADEs2.1NANANo
Avoiding Use of High Dose Opioid TherapyReducing ADEs3.1NANANo
Use of appropriate medications for asthma Respiratory Disease9.1NANANo
Appropriate treatment for adults with upper respiratory infection (URI) Respiratory Disease9.3PPRNET24NAYes
Chlamydia screening for women Women’s Health Care4.1310CMS153Yes
Osteoporosis screening for womenWomen’s Health Care4.239NAYes